COM:PHIOPHARMA
Phio Pharmaceuticals
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
phiopharma.com/ipo date
May 10, 2012
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint protein PD-1 for immunotherapy i...Show More